JAMES B. BREITMEYER

Insider Reports History

Signature
/s/Chase C. Leavitt, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by JAMES B. BREITMEYER:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 443K $220K $0.50 03 Jan 2024 Direct
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 197K $97.5K $0.50 03 Jan 2024 By Family Trust
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 15.4K $7.65K $0.50 03 Jan 2024 By Spouse
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Common Stock 733 $364 $0.50 03 Jan 2024 By Child
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Stock Option 28.4K 14 Feb 2024 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27.5K 21 Jun 2022 Direct
Oncternal Therapeutics, Inc. Chief Executive Officer, Director Stock Option 6.2K 14 Feb 2024 By Spouse
ZOGENIX, INC. Director Common Stock 0 $26.04 07 Mar 2022 Direct
ZOGENIX, INC. Director Stock Option (Right to Buy) 0 $26.09 07 Mar 2022 Direct

Insider Reports Filed by JAMES B. BREITMEYER

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ONCT Oncternal Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Executive Officer, Director 15 Feb 2024, 18:00
ONCT Oncternal Therapeutics, Inc. 03 Jan 2024 2 -$27.5K 4 Chief Executive Officer, Director 05 Jan 2024, 16:00
ONCT Oncternal Therapeutics, Inc. 02 Oct 2023 24 $0 4 Chief Executive Officer, Director 04 Oct 2023, 17:00
ONCT Oncternal Therapeutics, Inc. 03 Jul 2023 2 -$18.7K 4 Chief Executive Officer, Director 05 Jul 2023, 18:59
ONCT Oncternal Therapeutics, Inc. 13 Apr 2023 3 $43.9K 4 Chief Executive Officer, Director 17 Apr 2023, 06:00
ONCT Oncternal Therapeutics, Inc. 21 Feb 2023 3 $0 4 Chief Executive Officer, Director 24 Feb 2023, 15:00
ONCT Oncternal Therapeutics, Inc. 03 Jan 2023 2 -$29.7K 4 Chief Executive Officer, Director 05 Jan 2023, 17:00
ONCT Oncternal Therapeutics, Inc. 28 Jul 2022 4 $0 4 Chief Executive Officer, Director 01 Aug 2022, 18:18
OTIC OTONOMY, INC. 21 Jun 2022 1 $0 4 Director 23 Jun 2022, 16:30
ZGNX ZOGENIX, INC. 07 Mar 2022 7 $0 4 Director 09 Mar 2022, 18:16
ONCT Oncternal Therapeutics, Inc. 27 Jan 2022 1 $42.1K 4 Chief Executive Officer, Director 31 Jan 2022, 15:00
ONCT Oncternal Therapeutics, Inc. 20 Jan 2022 2 $0 4 Chief Executive Officer, Director 24 Jan 2022, 15:14
ONCT Oncternal Therapeutics, Inc. 03 Jan 2022 2 $0 4 Chief Executive Officer, Director 05 Jan 2022, 18:00
OTIC OTONOMY, INC. 22 Jun 2021 1 $0 4 Director 24 Jun 2021, 17:00
ZGNX ZOGENIX, INC. 27 May 2021 1 $0 4 Director 28 May 2021, 20:03